Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Panicker J. N., Eraksoy M.

MULTIPLE SCLEROSIS JOURNAL, cilt.27, sa.4, ss.621-629, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1177/1352458520926666
  • Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.621-629
  • Anahtar Kelimeler: Transcutaneous tibial nerve stimulation, pelvic floor muscle training, women, multiple sclerosis, overactive bladder, URINARY-TRACT DYSFUNCTION, QUALITY-OF-LIFE, NEUROMUSCULAR ELECTRICAL-STIMULATION, SYMPTOMS, INCONTINENCE, IMPACT
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Overactive bladder (OAB) is common in patients with multiple sclerosis (MS) with a limited number of treatment options. Objective: To investigate the effect of transcutaneous tibial nerve stimulation (TTNS) and pelvic floor muscle training (PFMT) with biofeedback on OAB symptoms in female MS patients. Methods: This study was conducted at the outpatient MS clinic in Istanbul. At baseline bladder diary, post-voiding residue (PVR), OAB, and Qualiveen Scales (QoL: Quality of Life; Siup: Specific Impact of Urinary Problems on QoL) were assessed. Patients were allocated to receive TTNS or PFMT daily for 6 weeks and reevaluated using the same tests. Results: Fifty-five patients (TTNS = 28, PFMT = 27) were included. Compared with baseline, both TTNS and PFMT groups improved in terms of OAB (p = 0.0001,p = 0.0001), Qualiveen-siup (p = 0.0001,p = 0.0001), Qualiveen-QoL (p = 0.002,p = 0.006), PVR (p = 0.0001,p = 0.21), frequency (p = 0.0001,p = 0.69), nocturia (p = 0.0001,p = 0.19), urgency (p = 0.0001,p = 0.0001), and urge incontinence (p = 0.0001,p = 0.0001). Between-group comparisons showed significant differences in 24-hour frequency (p = 0.002) in favor of TTNS. Conclusion: Our study demonstrates the efficacy of both TTNS and PFMT for managing OAB symptoms in MS, associated with a significant impact on QoL, but did not show superiority of the methods. Further studies are needed to explore differences between these two non-invasive treatments.